Welcome to our dedicated page for Accenture Plc Ireland SEC filings (Ticker: ACN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Accenture’s 300-page SEC disclosures can bury the datapoints that move the stock—cloud revenue mix, new bookings, and how many consultants billable hours really grew. Finding those nuggets across a dense 10-K, multiple 10-Q updates, and rapid-fire 8-K acquisitions is the challenge every ACN investor faces.
Stock Titan solves that problem by marrying real-time EDGAR feeds with AI-powered summaries that translate complex language into clear takeaways. Need the next Accenture quarterly earnings report 10-Q filing? It lands here seconds after the SEC posts it, alongside a plain-English breakdown of segment margins and headcount trends. Curious about Accenture insider trading Form 4 transactions? Our dashboard flags executive buys and sells the moment they’re filed, complete with historical context.
Explore every disclosure type in one place:
- Annual report 10-K—see how consulting versus managed-services revenue shifts, with Accenture annual report 10-K simplified by AI.
- Quarterly 10-Q—track bookings momentum and free-cash-flow swings.
- 8-K material events—instant reads on acquisitions, leadership changes, or dividend announcements: Accenture 8-K material events explained.
- Proxy statement—understand Accenture proxy statement executive compensation without sifting through tables.
- Form 4—monitor Accenture executive stock transactions Form 4 in real time.
Whether you’re modeling cash flow, comparing segment profitability, or watching Accenture Form 4 insider transactions real-time, Stock Titan delivers the data and plain-language insight you need—no PDF spelunking required.
Accenture plc (ACN) insider filing: Katherine Lee Clifford, listed as Accenture's Chief Leadership & HR Officer, acquired 52 Class A ordinary shares on 09/05/2025 at a price of $254.42 per share under Accenture's Voluntary Equity Investment Program. After the transaction she is reported to beneficially own 4,755 Class A ordinary shares. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact and dated 09/08/2025. The filing records a routine purchase under the company's equity program.
Julie Spellman Sweet, Chair and CEO of Accenture plc (ACN), purchased 152 Class A ordinary shares on 09/05/2025 at a price of $254.42 per share under Accenture's Voluntary Equity Investment Program. After the transaction she beneficially owns 8,440 shares, held directly. The Form 4 was signed on 09/08/2025 by an attorney-in-fact. The filing records the acquisition as a routine employee/insider purchase from the company program and discloses no derivatives, dispositions, or additional material terms.
Angie Y. Park, Accenture plc's Chief Financial Officer, reported an insider purchase of 89 Class A ordinary shares through the company's Voluntary Equity Investment Program at a price of $254.42 per share, increasing her direct beneficial ownership to 7,851 shares. The filing shows the transaction was executed pursuant to the issuer's employee equity program and recorded on the Form 4. This disclosure notifies investors of a small, direct insider buy by a senior officer under a routine company program.
Manish Sharma, Chief Services Officer at Accenture plc (ACN), purchased 72 Class A ordinary shares on 09/05/2025 at $254.42 per share under Accenture's Voluntary Equity Investment Program. After the purchase, Mr. Sharma beneficially owned 1,812 Class A ordinary shares, held directly. The Form 4 was signed by an attorney-in-fact on 09/08/2025. The filing identifies the reporting persons office address at Accentures Chicago headquarters and notes the transaction was a routine employee equity purchase under the company program.
John F. Walsh, an officer of Accenture plc, reported a purchase of Class A ordinary shares. On 09/05/2025 he acquired 108 shares at a price of $254.42 per share under Accenture's Voluntary Equity Investment Program, bringing his reported direct beneficial ownership to 16,298 Class A ordinary shares. The Form 4 was signed on behalf of Mr. Walsh by an attorney-in-fact on 09/08/2025.
Catherine Kiernan Hogan, Chief Operating Officer of Accenture plc (ACN), reported an equity purchase on 09/05/2025. She acquired 8,669 Class A ordinary shares at a price of $254.42 per share through Accenture's Voluntary Equity Investment Program. The filing also reports 2,048 Class A ordinary shares held indirectly in a family trust. The Form 4 was signed on behalf of Ms. Hogan by an attorney-in-fact on 09/08/2025. The disclosure is a routine officer purchase under the company plan.
Joel Unruch, Accenture plc's General Counsel and Corporate Secretary, acquired 108 Class A ordinary shares on 09/05/2025 at a reported price of $254.42 per share under Accenture's Voluntary Equity Investment Program. After the purchase, Mr. Unruch beneficially owns 17,807 shares directly. The transaction was reported on a Form 4 and executed by an attorney-in-fact on behalf of the reporting person. This appears to be a routine, plan-driven equity purchase rather than an open-market discretionary trade.
Catherine Kiernan Hogan, Chief Operating Officer of Accenture plc (ACN), filed an initial Form 3 reporting her beneficial ownership of Accenture securities. The filing shows 8,585 Class A ordinary shares held directly and 2,048 Class A ordinary shares held indirectly through a family trust. The event requiring the statement is dated 09/01/2025, and the Form 3 was signed on 09/02/2025.
Accenture plc reporting person Katherine Lee Clifford filed an Initial Statement of Beneficial Ownership showing direct ownership of 4,703 Class A ordinary shares. The Form 3 reports her role as Chief Leadership & HR Officer and indicates the transaction date requiring the statement was 09/01/2025. No derivative securities are reported. The filing was signed by an attorney-in-fact on 09/02/2025.
Jaime Ardila, a director of Accenture plc (ACN), received a grant of restricted share units (RSUs) on 08/15/2025 under the anti-dilution provisions of previously granted RSU awards to reflect Accenture's payment of a cash dividend. The Form 4 reports a non-derivative acquisition (transaction code A) with a reported price of $247.57. Following the reported transaction, Mr. Ardila beneficially owns 12,124 Class A ordinary shares directly. The filing was signed by an attorney-in-fact on 08/18/2025 and includes the explanatory remark that the RSUs were granted pursuant to anti-dilution provisions tied to a dividend.
FAQ
What is the current stock price of Accenture Plc Ireland (ACN)?
What is the market cap of Accenture Plc Ireland (ACN)?
